Anti-Acinetobacter baumannii single-chain variable fragments show direct bactericidal activity

سال انتشار: 1401
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 166

فایل این مقاله در 9 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_IJBMS-25-9_014

تاریخ نمایه سازی: 20 شهریور 1401

چکیده مقاله:

Objective(s): The high resistance rate of Acinetobacter baumannii and the limited number of available antibiotics have prompted a worldwide effort to develop effective antimicrobial agents. Accordingly, identifying single-chain variable fragment antibodies (scFvs), capable of exerting direct antibacterial activity in an immune system-independent manner, may be making immunocompromised patients more susceptible to A. baumannii infections.Materials and Methods: To isolate bactericidal scFvs targeting A. baumannii, we panned a large human scFv phage display library against whole-cell extensively drug-resistant (XDR) A. baumannii strains grown as biofilm or cultured with human blood or human peripheral blood mononuclear cells plus plasma. The binding of scFv-phages to A. baumannii was assessed by the dot-blot assay. Soluble scFvs, derived from the selected phages, were assessed based on their ability to bind and inhibit the growth of A. baumannii. Results: Five phage clones showed the highest reactivity toward A. baumannii. Among five soluble scFvs, derived from positive phage clones, two scFvs, EB۲۱۱ and EB۲۷۹, had high expression yields and displayed strong binding to A. baumannii compared with the controls. Moreover, XDR A. baumannii strains treated with positively-charged scFvs, including EB۲۱۱, EB۲۷۹, or a cocktail of EB۲۱۱ and EB۲۷۹ (۲۰۰ µg/ml), displayed lower viability (approximately ۵۰%, ۷۸%, and ۴۰% viability, respectively) compared with PBS-treated bacteria.Conclusion: These results suggest that combining last-resort antibiotics with bactericidal scFvs could provide promising outcomes in immunocompromised individuals with A. baumannii infections.

نویسندگان

Eilnaz Basardeh

Department of Mycobacteriology and Pulmonary Research, Pasteur Institute of Iran, Tehran, Iran

Somayeh Piri-Gavgani

Department of Mycobacteriology and Pulmonary Research, Pasteur Institute of Iran, Tehran, Iran

Behnoush Soltanmohammadi

Department of Mycobacteriology and Pulmonary Research, Pasteur Institute of Iran, Tehran, Iran

Mostafa Ghanei

Chemical Injuries Research Center, Systems Biology and Poisoning Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran

Mir Davood Omrani

Department of Medical Genetics, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Mahdieh Soezi

Department of Mycobacteriology and Pulmonary Research, Pasteur Institute of Iran, Tehran, Iran

Mohammad Ali Shokrgozar

National Cell Bank of Iran, Pasteur Institute of Iran, Tehran, Iran

Masoumeh Azizi

Molecular Medicine Department, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran

Abolfazl Fateh

Department of Mycobacteriology and Pulmonary Research, Pasteur Institute of Iran, Tehran, Iran

Farzam Vaziri

Department of Mycobacteriology and Pulmonary Research, Pasteur Institute of Iran, Tehran, Iran

Seyed Davar Siadat

Department of Mycobacteriology and Pulmonary Research, Pasteur Institute of Iran, Tehran, Iran

Zahra Sharifzadeh

Department of Immunology, Pasteur Institute of Iran, Tehran, Iran

Fatemeh Rahimi-Jamnani

Department of Mycobacteriology and Pulmonary Research, Pasteur Institute of Iran, Tehran, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Wang J, Xiong K, Pan Q, He W, Cong Y. ...
  • Isler B, Doi Y, Bonomo RA, Paterson DL. New treatment ...
  • Harding CM, Hennon SW, Feldman MF. Uncovering the mechanisms of ...
  • Zeighami H, Valadkhani F, Shapouri R, Samadi E, Haghi F. ...
  • Irani N, Basardeh E, Samiee F, Fateh A, Shooraj F, ...
  • Bassetti M, Labate L, Russo C, Vena A, Giacobbe DR. ...
  • Wang M, Zhang Y, Zhu J. Anti-Staphylococcus aureus single-chain variable ...
  • Soltanmohammadi B, Piri-Gavgani S, Basardeh E, Ghanei M, Azizi M, ...
  • Richard G, MacKenzie CR, Henry KA, Vinogradov E, Hall JC, ...
  • Xie X, McLean MD, Hall JC. Antibody-dependent cell-mediated cytotoxicity-and complement-dependent ...
  • Richard G. Investigating the bactericidal mechanism of anti-LPS antibodies against ...
  • LaRocca TJ, Katona LI, Thanassi DG, Benach JL. Bactericidal action ...
  • Ahamadi-Fesharaki R, Fateh A, Vaziri F, Solgi G, Siadat SD, ...
  • Jacobs AC, Sayood K, Olmsted SB, Blanchard CE, Hinrichs S, ...
  • Colquhoun JM, Rather PN. Insights into mechanisms of biofilm formation ...
  • Mostafa M, Siadat SD, Shahcheraghi F, Vaziri F, Japoni-Nejad A, ...
  • Weinstein MP. Performance standards for antimicrobial susceptibility testing: Clinical and ...
  • Kroeger LA, Hovde LB, Mitropoulos IF, Schafer J, Rotschafer JC. ...
  • Sheets MD, Amersdorfer P, Finnern R, Sargent P, Lindquist E, ...
  • Zarei B, Javidan Z, Fatemi E, Jamnani FR, Khatami S, ...
  • Eisenhardt SU, Schwarz M, Bassler N, Peter K. Subtractive single-chain ...
  • Brochet X, Lefranc MP, Giudicelli V. IMGT/V-QUEST: the highly customized ...
  • Gasteiger E HC, Gattiker A, Duvaud S, Wilkins MR, Appel ...
  • Soudeiha MA, Dahdouh EA, Azar E, Sarkis DK, Daoud Z. ...
  • Lee C-R, Lee JH, Park M, Park KS, Bae IK, ...
  • Weber BS, Harding CM, Feldman MF. Pathogenic Acinetobacter: from the ...
  • Boll JM, Crofts AA, Peters K, Cattoir V, Vollmer W, ...
  • Zahn M, Bhamidimarri SP, Baslé A, Winterhalter M, Van den ...
  • Sisakhtpour B, Mirzaei A, Karbasizadeh V, Hosseini N, Shabani M, ...
  • Vukotic G, Obradovic M, Novovic K, Di Luca M, Jovcic ...
  • Wintachai P, Phaonakrop N, Roytrakul S, Naknaen A, Pomwised R, ...
  • Goel VK, Kapil A. Monoclonal antibodies against the iron regulated ...
  • Wang-Lin SX, Balthasar JP. Pharmacokinetic and pharmacodynamic considerations for the ...
  • Russo TA, Beanan JM, Olson R, MacDonald U, Cox AD, ...
  • Nielsen TB, Pantapalangkoor P, Luna BM, Bruhn KW, Yan J, ...
  • Wang-Lin SX, Olson R, Beanan JM, MacDonald U, Russo TA, ...
  • Jahangiri A, Owlia P, Rasooli I, Salimian J, Derakhshanifar E, ...
  • Wang-Lin SX, Olson R, Beanan JM, MacDonald U, Balthasar JP, ...
  • Takada A, Watanabe S, Okazaki K, Kida H, Kawaoka Y. ...
  • Lee WS, Wheatley AK, Kent SJ, DeKosky BJ. Antibody-dependent enhancement ...
  • LaRocca TJ, Holthausen DJ, Hsieh C, Renken C, Mannella CA, ...
  • Monnier P, Vigouroux R, Tassew N. In vivo applications of ...
  • Li Z, Krippendorff B-F, Sharma S, Walz AC, Lavé T, ...
  • Smart M, Rajagopal A, Liu WK, Ha BY. Opposing effects ...
  • Wang Y, Wang L, Yang H, Xiao H, Farooq A, ...
  • De Oliveira DMP, Forde BM, Kidd TJ, Harris PNA, Schembri ...
  • Ashurst JV DA. Klebsiella Pneumonia.: In: StatPearls [Internet]. Treasure Island ...
  • Medrzycka-Dabrowska W, Lange S, Zorena K, Dabrowski S, Ozga D, ...
  • Gellatly SL, Hancock RE. Pseudomonas aeruginosa: new insights into pathogenesis ...
  • Turner KH, Everett J, Trivedi U, Rumbaugh KP, Whiteley M. ...
  • Babich T, Naucler P, Valik JK, Giske CG, Benito N, ...
  • Draper LA, Cotter PD, Hill C, Ross RP. The two ...
  • El-Sayed Ahmed MAE, Zhong LL, Shen C, Yang Y, Doi ...
  • Jahangiri A, Neshani A, Mirhosseini SA, Ghazvini K, Zare H, ...
  • Thomas VM, Brown RM, Ashcraft DS, Pankey GA. Synergistic effect ...
  • Hancock RE. The bacterial outer membrane as a drug barrier. ...
  • Wu X, Li Z, Li X, Tian Y, Fan Y, ...
  • van der Linden DS, Short D, Dittmann A, Yu PL. ...
  • Liu J, Chen F, Wang X, Peng H, Zhang H, ...
  • نمایش کامل مراجع